Results 231 to 240 of about 4,120,749 (298)

Unmanaged depression and chronic disease medication adherence in Medicare Advantage beneficiaries: A claims-based analysis. [PDF]

J Manag Care Spec Pharm
Nguyen D, Bowe A, Stepter A, Chung L, Wind H, Poonawalla I, Hames A.   +6 more
europepmc   +1 more source

Real-world use of botulinum toxin-A for post-stroke spasticity in the Netherlands: a retrospective claims study. [PDF]

J Rehabil Med
Van Wijk M, Verhoeven M, Lysen TS, Van Ballegooijen H, Geurts ACH.   +4 more
europepmc   +1 more source

Calcium sulphate and reduction in body weight: Evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006. [PDF]

EFSA J
EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), Turck D, Bohn T, Cámara M, Castenmiller J, de Henauw S, Hirsch-Ernst KI, Jos A, Maciuk A, Mangelsdorf I, McNulty B, Naska A, Pentieva K, Thies F, Drenjančević I, Craciun I, Fiolet T, Siani A.   +18 more
europepmc   +1 more source

Commentary: Musculoskeletal adverse events in dogs receiving bedinvetmab (Librela). [PDF]

Front Vet Sci
Lloyd A.
europepmc   +1 more source

Medicare Part D Use and Costs for Immune-Mediated Neurologic Therapies.

JAMA Netw Open
Wong KH, Zeng E, Smith TL, King JB, Marini E, Sorenson A, Hwang H, Stein C, Francis T, Rose JW, Reddy VK, de Havenon AH, Clardy SL.   +12 more
europepmc   +1 more source